Read more

April 19, 2020
1 min read
Save

Centinel Spine receives FDA approval for two-level total disc replacement system

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Centinel Spine LLC received FDA clearance for its prodisc L lumbar total disc replacement system, the first device of its kind to be clinically tested and approved for two-level use, according to a company press release.

The device has done “remarkably well” in long-term follow-up, Jack Zigler, MD, who performed the study, said in the release.

“I have now seen multiple two-level disc replacement patients with over 15-year follow-up who are still delighted with their clinical results — and have not needed additional surgery that is commonly required after initial fusion surgery. Patients with two-level disc replacement are among my most grateful patients,” Zigler said in the release.

“The prodisc technology's remarkable safety and efficacy profile is a tribute to the design of the device,” Steve Murray, CEO of Centinel Spine, said in the release. “The longevity of the prodisc technology is due to the design principles of a stable bone interface, a consistent mechanism of action-enabling guided motion, and instrumentation that facilitates efficient and reliable implantation.”

 

Reference:

https://centinelspine.press/2020/04/13/centinel-spine-announces-fda-approval-for-two-level-prodisc-l-total-disc-replacement/